[1] A MALEKJAHANI, S SINDHWANI, A M SYED et al. Engineering steps for mobile point-of-care diagnostic devices. Accounts of Chemical Research, 2406-2414(2019).
[2] H HE, L LIU, E E MORIN et al. Survey of clinical translation of cancer nanomedicines—lessons learned from successes and failures. Accounts of Chemical Research, 2445-2461(2019).
[3] H HUANG, W FENG, Y CHEN et al. Inorganic nanoparticles in clinical trials and translations. Nano Today(2020).
[4] H HUANG, W FENG, Y CHEN. Two-dimensional biomaterials: material science, biological effect and biomedical engineering applications. Chemical Society Reviews, 11381-11485(2021).
[5] B PELAZ, C H ALEXIOU, R A ALVAREZ-PUEBLA et al. Diverse applications of nanomedicine. ACS Nano, 2313-2381(2017).
[6] C BURDA, X CHEN, R NARAYANAN et al. Chemistry and properties of nanocrystals of different shapes. Chemical Reviews, 1025-1102(2005).
[7] H XIANG, Y CHEN. Materdicine: interdiscipline of materials and medicine. VIEW, 20200016-29(2020).
[8] J J SHI, P W KANTOFF, R WOOSTER et al. Cancer nanomedicine: progress, challenges and opportunities. Nature Reviews Cancer, 20-37(2017).
[9] D IRBY, C DU, F LI. Lipid-drug conjugate for enhancing drug delivery. Molecular Pharmaceutics, 1325-1338(2017).
[10] S MURA, J NICOLAS, P COUVREUR. Stimuli-responsive nanocarriers for drug delivery. Nature Materials, 991-1003(2013).
[11] J NICOLAS, S MURA, D BRAMBILLA et al. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chemical Society Reviews, 1147-1235(2013).
[12] S KUNJACHAN, J EHLING, G STORM et al. Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects. Chemical Reviews, 10907-10937(2015).
[13] H M CHEN, W Z ZHANG, G Z ZHU et al. Rethinking cancer nanotheranostics. Nature Reviews Materials, 17024-18(2017).
[14] C WANG, W HUANG, Y ZHOU et al. 3D printing of bone tissue engineering scaffolds. Bioactive Materials, 82-91(2020).
[15] B KAUR, S KUMAR, B K KAUSHIK. Recent advancements in optical biosensors for cancer detection. Biosensors and Bioelectronics(2022).
[16] A J HUH, Y J KWON. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.. Journal of Controlled Release, 128-145(2011).
[17] Y DUAN, B LIU. Recent advances of optical imaging in the second near-infrared window. Advanced Materials, 1802394-19(2018).
[18] L Y HUANG, S ZHU, R CUI et al. Noninvasive in vivo imaging in the second near-infrared window by inorganic nanoparticle-based fluorescent probes. Analytical Chemistry, 535-542(2019).
[19] H LIN, S GAO, C DAI et al. A two-dimensional biodegradable niobium carbide (MXene) for photothermal tumor eradication in NIR-I and NIR-II biowindows. Journal of the American Chemical Society, 16235-16247(2017).
[20] Q YANG, Z HU, S ZHU et al. Donor engineering for NIR-II molecular fluorophores with enhanced fluorescent performance. Journal of the American Chemical Society, 1715-1724(2018).
[21] H C YANG, R F LI, Y J ZHANG et al. Colloidal alloyed quantum dots with enhanced photoluminescence quantum yield in the NIR-II window. Journal of the American Chemical Society, 2601-2607(2021).
[22] Y FAN, S WANG, F ZHANG. Optical multiplexed bioassays for improved biomedical diagnostics. Angewandte Chemie International Edition, 13342-13353(2019).
[23] K WELSHER, Z LIU, SP SHERLOCK et al. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. Nature Nanotechnology, 773-780(2009).
[24] B CHANG, D LI, Y REN et al. A phosphorescent probe for in vivo imaging in the second near-infrared window. Nature Biomedical Engineering, 629-639(2022).
[25] Q WANG, Z LIANG, F LI et al. Dynamically switchable magnetic resonance imaging contrast agents. Exploration, 20210009-8(2021).
[26] D KIM, J KIM, Y I PARK et al. Recent development of inorganic nanoparticles for biomedical imaging. ACS Central Science, 324-336(2018).
[27] Z XU, C LIU, S ZHAO et al. Molecular sensors for NMR-based detection. Chemical Reviews, 195-230(2018).
[28] M H CHO, S H SHIN, S H PARK et al. Targeted, stimuli-responsive, and theranostic 19F magnetic resonance imaging probes. Bioconjugate Chemistry, 2502-2518(2019).
[29] X ZHAO, G DUAN, K WU et al. Intelligent metamaterials based on nonlinearity for magnetic resonance imaging. Advanced Materials, 1905461-7(2019).
[30] D DELCASSIAN, I LUZHANSKY, V SPANOUDAKI et al. Magnetic retrieval of encapsulated beta cell transplants from diabetic mice using dual-function MRI visible and retrievable microcapsules. Advanced Materials, 1904502-10(2020).
[31] J ZHANG, Y YUAN, M GAO et al. Carbon dots as a new class of diamagnetic chemical exchange saturation transfer (diacest) MRI contrast agents. Angewandte Chemie International Edition, 9871-9875(2019).
[32] P ZHANG, Y HOU, J ZENG et al. Coordinatively unsaturated Fe3+ based activatable probes for enhanced MRI and therapy of tumors. Angewandte Chemie International Edition, 11088(2019).
[33] C DAI, Y CHEN, X X JING et al. Two-dimensional tantalum carbide (MXenes) composite nanosheets for multiple imaging- guided photothermal tumor ablation. ACS Nano, 12696-12712(2017).
[34] C DAI, H LIN, G XU et al. Biocompatible 2D titanium carbide (MXenes) composite nanosheets for pH-responsive MRI-guided tumor hyperthermia. Chemistry of Materials, 8637-8652(2017).
[35] Z LIU, H LIN, M L ZHAO et al. 2D superparamagnetic tantalum carbide composite MXenes for efficient breast-cancer theranostics. Theranostics, 1648-1664(2018).
[36] Z LIU, M L ZHAO, H LIN et al. 2D magnetic titanium carbide MXene for cancer theranostics. Journal of Materials Chemistry B, 3541-3548(2018).
[37] Y CAO, T WU, K ZHANG et al. Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy. ACS Nano, 1499-1510(2019).
[38] A BAR-ZION, A NOURMAHNAD, D R MITTELSTEIN et al. Acoustically triggered mechanotherapy using genetically encoded gas vesicles. Nature Nanotechnology, 1403-1412(2021).
[39] Y LIU, P BHATTARAI, Z DAI et al. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chemical Society Reviews, 2053-2108(2019).
[40] X LI, Z CAI, L P JIANG et al. Metal-ligand coordination nanomaterials for biomedical imaging. Bioconjugate Chemistry, 332-339(2019).
[41] Z MENG, X ZHOU, J SHE et al. Ultrasound-responsive conversion of microbubbles to nanoparticles to enable background-free in vivo photoacoustic imaging. Nano Letters, 8109-8117(2019).
[42] Y S CHEN, Y ZHAO, S J YOON et al. Miniature gold nanorods for photoacoustic molecular imaging in the second near-infrared optical window. Nature Nanotechnology, 465-472(2019).
[43] J KIM, P CHHOUR, J HSU et al. Use of nanoparticle contrast agents for cell tracking with computed tomography. Bioconjugate Chemistry, 1581-1597(2017).
[44] B G ZHOU, H H YIN, C H DONG et al. Biodegradable and excretable 2D W1.33C i-MXene with vacancy ordering for theory- oriented cancer nanotheranostics in near-infrared biowindow. Advanced Science, 2101043-13(2021).
[45] J XU, R SHI, G CHEN et al. All-in-one theranostic nanomedicine with ultrabright second near-infrared emission for tumor- modulated bioimaging and chemodynamic/photodynamic therapy. ACS Nano, 9613-9625(2020).
[46] H S JUNG, P VERWILST, A SHARMA et al. Organic molecule- based photothermal agents: an expanding photothermal therapy universe. Chemical Society Reviews, 2280-2297(2018).
[47] H WANG, J CHANG, M SHI et al. A dual-targeted organic photothermal agent for enhanced photothermal therapy. Angewandte Chemie International Edition, 1073(2019).
[48] Z YU, W HU, H ZHAO et al. Generating new cross-relaxation pathways by coating prussian blue on NaNdF4 to fabricate enhanced photothermal agents. Angewandte Chemie International Edition, 8536-8540(2019).
[49] Y JIANG, J LI, X ZHEN et al. Dual-peak absorbing semiconducting copolymer nanoparticles for first and second near-infrared window photothermal therapy: a comparative study. Advanced Materials, 1705980-7(2018).
[50] X ZHEN, C XIE, K PU. Temperature-correlated afterglow of a semiconducting polymer nanococktail for imaging-guided photothermal therapy. Angewandte Chemie International Edition, 4006(2018).
[51] A M SMITH, M C MANCINI, S NIE. Second window for in vivo imaging. Nature Nanotechnology, 710-711(2009).
[52] J ZHOU, Y JIANG, S HOU et al. Compact plasmonic blackbody for cancer theranosis in the near-infrared II window. ACS Nano, 2643-2651(2018).
[53] Y CHENG, F YANG, G XIANG et al. Ultrathin tellurium oxide/ ammonium tungsten bronze nanoribbon for multimodality imaging and second near-infrared region photothermal therapy. Nano Letters, 1179-1189(2019).
[54] J CUI, R JIANG, C GUO et al. Fluorine grafted Cu7S4-Au heterodimers for multimodal imaging guided photothermal therapy with high penetration depth. Journal of the American Chemical Society, 5890-5894(2018).
[55] S SUN, Y SONG, J CHEN et al. NIR-I and NIR-II irradiation tumor ablation using NbS2 nanosheets as the photothermal agent. Nanoscale, 18300-18310(2021).
[56] H J XIANG, Y CHEN. Energy-converting nanomedicine. Small, 1805339-31(2019).
[57] H HU, X Q QIAN, Y CHEN. Microalgae-enabled photosynthetic alleviation of tumor hypoxia for enhanced nanotherapies. Science Bulletin, 1869-1871(2020).
[58] B D CHEN, H J XIANG, S S PAN et al. Advanced theragenerative biomaterials with therapeutic and regeneration multifunctionality. Advanced Functional Materials, 2002621-27(2020).
[59] W FENG, Y CHEN. Chemoreactive nanomedicine. Journal of Materials Chemistry B, 6753-6764(2020).
[60] S S LUCKY, K C SOO, Y ZHANG. Nanoparticles in photodynamic therapy. Chemical Reviews, 1990-2042(2015).
[61] M CHANG, W FENG, L DING et al. Persistent luminescence phosphor as in-vivo light source for tumoral cyanobacterial photosynthetic oxygenation and photodynamic therapy. Bioactive Materials(2022).
[62] L ZHOU, C DONG, L DING et al. Targeting ferroptosis synergistically sensitizes apoptotic sonodynamic anti-tumor nanotherapy. Nano Today(2021).
[63] Y SHEN, L CHEN, X GUAN et al. Tailoring chemoimmunostimulant bioscaffolds for inhibiting tumor growth and metastasis after incomplete microwave ablation. ACS Nano, 20414-20429(2021).
[64] I MELLMAN, G COUKOS, G DRANOFF. Cancer immunotherapy comes of age.. Nature, 480-489(2011).
[65] A RIBAS, J D WOLCHOK. Cancer immunotherapy using checkpoint blockade. Science, 1350-1355(2018).
[66] K M MAHONEY, P D RENNERT, G J FREEMAN. Combination cancer immunotherapy and new immunomodulatory targets. Nature Reviews Drug Discovery, 561-584(2015).
[67] M VANNEMAN, G DRANOFF. Combining immunotherapy and targeted therapies in cancer treatment. Nature Reviews Cancer, 237-251(2012).
[68] W SANG, Z ZHANG, Y DAI et al. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy. Chemical Society Reviews, 3771-3810(2019).
[69] IV CW SHIELDS, L W WANG, M A EVANS et al. Materials for immunotherapy. Advanced Materials, 1901633-56(2020).
[70] J NAM, S SON, K S PARK et al. Cancer nanomedicine for combination cancer immunotherapy. Nature Reviews Materials, 398-414(2019).
[71] W SONG, S N MUSETTI, L HUANG. Nanomaterials for cancer immunotherapy. Biomaterials(2017).
[72] A S CHEUNG, D J MOONEY. Engineered materials for cancer immunotherapy. Nano Today, 511-531(2015).
[73] Y LIU, L WANG, Q SONG et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti- PD-L1 therapy for malignant pleural effusion. Nature Nanotechnology, 206-216(2022).
[74] Y ZHENG, X LI, C DONG et al. Ultrasound-augmented nanocatalytic ferroptosis reverses chemotherapeutic resistance and induces synergistic tumor nanotherapy. Advanced Functional Materials, 2107529-17(2022).
[75] W XU, C DONG, H HU et al. Engineering Janus chemoreactive nanosonosensitizers for bilaterally augmented sonodynamic and chemodynamic cancer nanotherapy. Advanced Functional Materials, 2103134-13(2021).
[76] H XIANG, C YOU, W LIU et al. Chemotherapy-enabled /augmented cascade catalytic tumor-oxidative nanotherapy. Biomaterials(2021).
[77] H X WANG, M LI, C M LEE et al. CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery. Chemical Reviews, 9874-9906(2017).
[78] Y LYU, S S HE, J C LI et al. A photolabile semiconducting polymer nanotransducer for near-infrared regulation of CRISPR/ Cas9 gene editing. Angewandte Chemie International Edition, 18197-18201(2019).
[79] Q CHENG, T WEI, L FARBIAK et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nature Nanotechnology, 313-320(2020).
[80] H YIN, B ZHOU, C DONG et al. CRISPR/Cas9-2D silicene gene-editing nanosystem for remote NIR-II-induced tumor microenvironment reprogramming and augmented photonic tumor ablation. Advanced Functional Materials, 2107093-12(2021).
[81] H YIN, L SUN, Y PU et al. Ultrasound-controlled CRISPR/Cas9 system augments sonodynamic therapy of hepatocellular carcinoma. ACS Central Science, 2049-2062(2021).
[82] M LI, H MA, F HAN et al. Microbially catalyzed biomaterials for bone regeneration. Advanced Materials, 2104829-13(2021).
[83] Y ZHOU, C WU, J CHANG. Bioceramics to regulate stem cells and their microenvironment for tissue regeneration. Materials Today(2019).
[84] T LI, J CHANG, Y ZHU et al. 3D printing of bioinspired biomaterials for tissue regeneration. Advanced Healthcare Materials, 2000208-17(2020).
[85] M M STEVENS. Biomaterials for bone tissue engineering. Materials Today, 18-25(2008).
[86] D E DISCHER, D J MOONEY, P W ZANDSTRA. Growth factors, matrices, and forces combine and control stem cells. Science, 1673-1677(2009).
[87] B GEIGER, J P SPATZ, A D BERSHADSKY. Environmental sensing through focal adhesions. Nature Reviews Molecular Cell Biology, 21-33(2009).
[88] L WANG, Q YANG, M HUO et al. Engineering single-atomic iron-catalyst-integrated 3D-printed bioscaffolds for osteosarcoma destruction with antibacterial and bone defect regeneration bioactivity. Advanced Materials, 2100150-12(2021).
[89] M SOMMARIVA, NOCI V LE, F BIANCHI et al. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cellular and Molecular Life Sciences, 2739-2749(2020).
[90] W YANG, J I PETERS, R O WILLIAMS. Inhaled nanoparticles-a current review. International Journal of Pharmaceutics, 239-247(2008).
[91] J W MYERSON, P N PATEL, K M RUBEY et al. Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation. Nature Nanotechnology, 86-97(2022).
[92] E VASARMIDI, E TSITOURA, D A SPANDIDOS et al. Pulmonary fibrosis in the aftermath of the COVID-19 era.. Experimental and Therapeutic Medicine, 2557-2560(2020).
[93] R CRISAN-DABIJA, C A PAVEL, I V POPA et al. “A chain only as strong as its weakest link”: an up-to-date literature review on the bidirectional interaction of pulmonary fibrosis and COVID-19. Journal of Proteome Research, 4327-4338(2020).
[94] D J LEDERER, F J MARTINEZ. Idiopathic pulmonary fibrosis. New England Journal of Medicine, 1811-1823(2018).
[95] L RICHELDI, H R COLLARD, M G JONES. Idiopathic pulmonary fibrosis. Lancet, 1941-1952(2017).
[96] W MERKT, M BUENO, AL MORA et al. Senotherapeutics: targeting senescence in idiopathic pulmonary fibrosis. Seminars in Cell & Developmental Biology(2020).
[97] E S MALSIN, D W KAMP. The mitochondria in lung fibrosis: Friend or foe. Translational Research(2018).
[98] G YU, A TZOUVELEKIS, R WANG et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nature Medicine, 39-49(2018).
[99] J SALEH, C PEYSSONNAUX, K K SINGH et al. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion(2020).
[100] T HUANG, T ZHANG, X JIANG et al. Iron oxide nanoparticles augment the intercellular mitochondrial transfer-mediated therapy. Science Advances, eabj0534-15(2021).
[101] W FENG, X G HAN, H HU et al. 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases. Nature Communications, 2203-16(2021).
[102] K WANG, Y ZHANG, W MAO et al. Engineering ultrasmall ferroptosis-targeting and reactive oxygen/nitrogen species- scavenging nanozyme for alleviating acute kidney injury. Advanced Functional Materials, 2109221-13(2022).
[103] Z TANG, M HUO, Y JU et al. Nanoprotection against retinal pigment epithelium degeneration via ferroptosis inhibition. Small Methods, 2100848-14(2021).
[104] J WU, H YUK, TIFFANY L SARRAFIAN et al. An off-the-shelf bioadhesive patch for sutureless repair of gastrointestinal defects. Science Translational Medicine, eabh2857-13.
[105] S J KIM, S J CHOI, J S JANG et al. Innovative nanosensor for disease diagnosis. Accounts of Chemical Research, 1587-1596(2017).
[106] Z M TANG, N KONG, X C ZHANG et al. A materials-science perspective on tackling COVID-19. Nature Reviews Materials, 847-860(2020).
[107] N FAROKHZAD, W TAO. Materials chemistry-enabled platforms in detecting sexually transmitted infections: progress towards point-of-care tests. Trends in Chemistry, 589-602(2021).
[108] M M GONG, D SINTON. Turning the page: advancing paper-based microfluidics for broad diagnostic application. Chemical Reviews, 8447-8480(2017).
[109] X HUANG, Y LIU, B YUNG et al. Nanotechnology-enhanced no-wash biosensors for in vitro diagnostics of cancer. ACS Nano, 5238-5292(2017).
[110] C WANG, B QI, M LIN et al. Continuous monitoring of deep-tissue haemodynamics with stretchable ultrasonic phased arrays. Nature Biomedical Engineering, 749-758(2021).
[111] T CHAIBUN, J PUENPA, T NGAMDEE et al. Rapid electrochemical detection of coronavirus SARS-Cov-2. Nature Communications, 802-10(2021).
[112] B GATES. Responding to COVID-19-a once-in-a-century pandemic. New England Journal of Medicine, 1677-1679(2020).
[113] A S LAURING, J FRYDMAN, R ANDINO. The role of mutational robustness in RNA virus evolution. Nature Reviews Microbiology, 327-336(2013).
[114] G SEO, G LEE, M J KIM et al. Rapid detection of COVID-19 causative virus (SARS-Cov-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano, 5135-5142(2020).
[115] G XIAO, J HE, X CHEN et al. A wearable, cotton thread/paper- based microfluidic device coupled with smartphone for sweat glucose sensing. Cellulose, 4553-4562(2019).
[116] T LI, L CHEN, X YANG et al. A flexible pressure sensor based on an MXene-textile network structure. Journal of Materials Chemistry C, 1022-1027(2019).
[117] P P KALELKAR, M RIDDICK, A J GARCIA. Biomaterial-based antimicrobial therapies for the treatment of bacterial infections. Nature Reviews Materials, 39-54(2022).
[118] J F LI, Z Y LI, X M LIU et al. Interfacial engineering of Bi2S3/Ti3C2Tx MXene based on work function for rapid photo- excited bacteria-killing. Nature Communications, 1224-10(2021).
[119] N DURÁN, M DURÁN, JESUS MB DE et al. Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomedicine: Nanotechnology, Biology and Medicine, 789-799(2016).
[120] A PANÁČEK, L KVÍTEK, M SMÉKALOVÁ et al. Bacterial resistance to silver nanoparticles and how to overcome it.. Nature Nanotechnology, 65-71(2018).
[121] L M STABRYLA, K A JOHNSTON, N A DIEMLER et al. Role of bacterial motility in differential resistance mechanisms of silver nanoparticles and silver ions. Nature Nanotechnology, 996-1003(2021).
[122] B LI, W WANG, W SONG et al. Antiviral and anti-inflammatory treatment with multifunctional alveolar macrophage-like nanoparticles in a surrogate mouse model of COVID-19. Advanced Science, 2003556-14(2021).
[123] C VALLIERES, A L HOOK, Y HE et al. Discovery of (meth)acrylate polymers that resist colonization by fungi associated with pathogenesis and biodeterioration. Science Advances, eaba6574-12(2020).
